The molecular mechanism of TCR repertoire generation and coreceptor expression
TCR库生成和辅助受体表达的分子机制
基本信息
- 批准号:07457591
- 负责人:
- 金额:$ 1.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To study molecular mechanism of positive selection (PS) process for generating TCR repertoire, we analyzed related molecules for regulating expression of TCR and CD4 and_CD8 co-receptor. In use of gene manipulating mice, we proved followings.(1) TCR expression which increased randomly at DP stage was down-regulated without PS by TCR-MHC interaction but maintained its density without an appropriate TCR mediated signal. This conclusion is not consistent with the previous hypothesis that TCR expression on DP cells is originally low but it is induced to raise up when DP cells receive TCR mediated PS signal while TCR expression is not increased without TCR signal. However, our findings is helpful to resolve the question raised in the previous hypothesis how low TCR can recognize MHC molecules with low avidity which may positively select DP cells, resulting in DP cells activation for high TCR expression. (2) CD45 on DP cells was closely involved in down-regulation of TCR expression, which was overcome by TCR mediated signal. (3) We explored to detect tyrosine phosphorylation of intracellular substrates of thymocytes in the in vivo condition, and demonstrated that ZAP-70 is highly phosphorylated in PS process for CD8SP generation but not for CD4SP cell lineage. This result is consistent with the recent observation reported in a human patient possessing with abnormal ZAP-70, in which CD8SP cells did not develop but CD4SP cells were found though their number was small. These findings suggest an asymmetric mechanism for down regulation of CD4 and CD8 in DP thymocytes. (4) CD4 mature T cells are induced further functional development into Th1 and Th2 cells by non-MHC related regulation.
为了研究TCR库生成的分子机制,我们分析了调节TCR、CD4和_cd8共受体表达的相关分子。在基因操纵小鼠的使用中,我们证明了以下几点。(1)在DP期随机升高的TCR表达在没有PS的情况下被TCR- mhc相互作用下调,但在没有适当的TCR介导信号的情况下保持其密度。这一结论与之前的假设不一致,即DP细胞上TCR的表达本来是低的,但当DP细胞接受TCR介导的PS信号时,TCR的表达被诱导升高,而没有TCR信号时,TCR的表达不增加。然而,我们的研究结果有助于解决先前假设中提出的问题,即低TCR如何以低亲和度识别MHC分子,从而可能正向选择DP细胞,导致DP细胞激活以高TCR表达。(2) DP细胞上的CD45与TCR表达的下调密切相关,而TCR介导的信号能够克服这种下调。(3)我们探索了体内胸腺细胞胞内底物酪氨酸磷酸化的检测,发现ZAP-70在CD8SP细胞系的PS过程中高度磷酸化,而在CD4SP细胞系中则没有磷酸化。这一结果与最近报道的一例人类ZAP-70异常患者的观察结果一致,该患者未出现CD8SP细胞,但发现了CD4SP细胞,但数量较少。这些发现提示了DP胸腺细胞CD4和CD8下调的不对称机制。(4) CD4成熟T细胞通过非mhc相关调控进一步功能发育为Th1和Th2细胞。
项目成果
期刊论文数量(35)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Y.Tanaka,A.Takahashi,K.Watanabe,K.Takayama,et al.: "A pivotal role of IL-12 in Th1-dependent mouse liver injury." Int.Immunol.6. 569-576 (1996)
Y.Tanaka、A.Takahashi、K.Watanabe、K.Takayama 等人:“IL-12 在 Th1 依赖性小鼠肝损伤中的关键作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
S.Ohta: "Tumor-associated glycoantigen,sialy Lewis″ as a target for bispecific antibody-directed adoptive tumor immunotherapy." Immunol.Letters. 44. 35-40 (1995)
S.Ohta:“肿瘤相关糖抗原,sialy Lewis”作为双特异性抗体导向的过继性肿瘤免疫疗法的靶标。”《免疫快报》44. 35-40 (1995)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Nishimura,K.Watanabe,U.Lee,T.Yahata,M.Kobayashi,et al.: "Phenotype and functional characteristics of in vivo-induced interleukin-12-activated killer cells." Immunol.Letters. 48. 167-174 (1995)
T.Nishimura、K.Watanabe、U.Lee、T.Yahata、M.Kobayashi 等人:“体内诱导的白细胞介素 12 激活杀伤细胞的表型和功能特征。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K.Hattori: "Bispecific antibody-mediated cytotoxicity by CD4^+ and CD8+-activated Tcells genrerated from leukemia patients after allogeneic bone marros transplantation." Bone Marraw Transplant.15. 193-198 (1995)
K.Hattori:“双特异性抗体介导的 CD4+ 和 CD8 激活 T 细胞的细胞毒性来自同种异体骨髓移植后的白血病患者。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
S.Kuge: "Superantigen-induced human CD4^+ helper/killer T cell Phenomenon:Selective induction of Th1 type of Helper/killer T cells and application to tumor immunotherapy." J.Immunol.154. 1777-1785 (1995)
S.Kuge:“超抗原诱导的人类 CD4^ 辅助/杀伤性 T 细胞现象:选择性诱导 Th1 型辅助/杀伤性 T 细胞及其在肿瘤免疫治疗中的应用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HABU Sonoko其他文献
Involvement of commensal bacteria in thymic Aire expression.
共生细菌参与胸腺 Aire 表达。
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
NAKAJIMA Akihito;NEGISHI Naoko;TSURUI Hiromichi;NANNO Masanobu;YAGITA Hideo;OKUMURA Ko;HABU Sonoko - 通讯作者:
HABU Sonoko
HABU Sonoko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HABU Sonoko', 18)}}的其他基金
Molecular mechanism of T cell development in Notch signal mediated nitch
Notch信号介导的缺口中T细胞发育的分子机制
- 批准号:
21390154 - 财政年份:2009
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Differentiation-induction of antibody producing human B cells from cord blood CD34+ cells in mice for generating monoclonal antibody used in clinical therapy
从小鼠脐带血 CD34 细胞中分化诱导产生抗体的人 B 细胞,以产生用于临床治疗的单克隆抗体
- 批准号:
12557032 - 财政年份:2000
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulatory mechanism of T cell activation in NOD mice
NOD小鼠T细胞活化的调控机制
- 批准号:
09044336 - 财政年份:1997
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for international Scientific Research
Molecular mechanism of selective development in thymocytes analysing DP specific molcules
胸腺细胞选择性发育的分子机制分析DP特异性分子
- 批准号:
09470098 - 财政年份:1997
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Joint study of antigen presenting activity in NOD mice
NOD小鼠抗原呈递活性的联合研究
- 批准号:
08044322 - 财政年份:1996
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for international Scientific Research
Models for studying mechanism of autoimmune disease
研究自身免疫性疾病机制的模型
- 批准号:
07044295 - 财政年份:1995
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for international Scientific Research
Establishment of in vitro experimental model for studying molecular mechanism of self-reactive T cell clone
研究自身反应性T细胞克隆分子机制的体外实验模型的建立
- 批准号:
04454213 - 财政年份:1992
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Studies of selection mechanism against self reactive T cell clones during intrathymic development
胸腺内发育过程中针对自身反应性T细胞克隆的选择机制研究
- 批准号:
03044130 - 财政年份:1991
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for international Scientific Research
Study of T lymphocytes which develop in the extrathymic tissues.
研究胸腺外组织中发育的 T 淋巴细胞。
- 批准号:
61480139 - 财政年份:1986
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
酪氨酸激酶ZAP-70与核糖体蛋白相互作用导致慢性淋巴细胞白血病预后不良的分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Embelin靶向N-Shc/ZAP-70/PI3K/Akt轴调控CD8+T细胞在炎症相关性结直肠癌中的机制研究
- 批准号:81902427
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Functional characterization of cysteine residues in the regulation of Zap-70 activity in physiology and disease
半胱氨酸残基在生理和疾病中调节 Zap-70 活性的功能表征
- 批准号:
416907033 - 财政年份:2019
- 资助金额:
$ 1.22万 - 项目类别:
Research Grants
Inhibition of ZAP-70 to selectively attenuate autoimmune disease-inducing T cells
抑制 ZAP-70 可选择性减弱自身免疫性疾病诱导 T 细胞
- 批准号:
9306567 - 财政年份:2016
- 资助金额:
$ 1.22万 - 项目类别:
Functional characterization of cysteines in Lck and Zap-70 and identification of new targets of oxidation in lymphocytes under physiological and pathological conditions.
Lck 和 Zap-70 中半胱氨酸的功能表征以及生理和病理条件下淋巴细胞氧化新靶点的鉴定。
- 批准号:
251953707 - 财政年份:2014
- 资助金额:
$ 1.22万 - 项目类别:
Priority Programmes
Inhibition of ZAP-70 to selectively attenuate autoimmune disease-inducing T cells
抑制 ZAP-70 可选择性减弱自身免疫性疾病诱导 T 细胞
- 批准号:
8928965 - 财政年份:2014
- 资助金额:
$ 1.22万 - 项目类别:
Inhibition of ZAP-70 to selectively attenuate autoimmune disease-inducing T cells
抑制 ZAP-70 可选择性减弱自身免疫性疾病诱导 T 细胞
- 批准号:
9132670 - 财政年份:2014
- 资助金额:
$ 1.22万 - 项目类别:
Inhibition of ZAP-70 to selectively attenuate autoimmune disease-inducing T cells
抑制 ZAP-70 可选择性减弱自身免疫性疾病诱导 T 细胞
- 批准号:
8617722 - 财政年份:2014
- 资助金额:
$ 1.22万 - 项目类别:
Small Molecule Inhibitors of ZAP-70 for the Treatment of Autoimmune Disorders
ZAP-70 小分子抑制剂用于治疗自身免疫性疾病
- 批准号:
8520902 - 财政年份:2013
- 资助金额:
$ 1.22万 - 项目类别:
An allosteric inhibitor of ZAP-70 as a novel therapeutic for autoimmune disease
ZAP-70 的变构抑制剂作为自身免疫性疾病的新型治疗方法
- 批准号:
7853999 - 财政年份:2009
- 资助金额:
$ 1.22万 - 项目类别:
An allosteric inhibitor of ZAP-70 as a novel therapeutic for autoimmune disease
ZAP-70 的变构抑制剂作为自身免疫性疾病的新型治疗方法
- 批准号:
7941045 - 财政年份:2009
- 资助金额:
$ 1.22万 - 项目类别:
Comparison of SKG and ZAP-70 YYAA mutant mice in the development of arthritis
SKG和ZAP-70 YYAA突变小鼠关节炎发生的比较
- 批准号:
7618802 - 财政年份:2008
- 资助金额:
$ 1.22万 - 项目类别: